38 completed, 8 terminated, 7 unknown, 4 recruiting. 60 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 60 | Completed 38, Terminated 8, Unknown 7, Recruiting 4, Not yet recruiting 2, Withdrawn 1 |
Follow Fluoxetine: new trials by email Literature Review of Fluoxetine trials Research Report on Fluoxetine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Disposition Kinetics of Dolutegravir Among People Living With HIV With Major Depression in Nigeria Fluoxetine, Cognitive-behavioral therapy - Depression, HIV | Phase 4 | Not yet recruiting | University of Ibadan | 168 | 2025-08-14 | 2025-08-08 |
| Identifying and Treating Depression in the Orthopaedic Trauma Population Fluoxetine 20 MG, Duloxetine 30 MG, Observation - Depression | Phase 4 | Recruiting | Wake Forest University Health Sciences | 100 | 2025-06-25 | 2026-05-22 |
| TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children Fluoxetine, Escitalopram, Sertralin - Depression - Major Depressive Disorder, Depressive Episodes | Phase 4 | Recruiting | Poznan University of Medical Sciences | 180 | 2025-04-03 | 2026-03-18 |
| Can Immediate Post-injury Fluoxetine Improve the Recovery Trajectories of Victims in Bodily Trauma? Fluoxetine, Placebo - Musculoskeletal Injury | Phase 4 | Recruiting | University of Florida | 200 | 2024-03-01 | 2026-04-13 |
| Efficacy of Hydroxyzine for Patients With Panic Disorder Hydroxyzine, Escitalopram Oxalate - Panic Disorder | Phase 4 | Not yet recruiting | Sultan Qaboos University | 80 | 2023-12-30 | 2023-02-21 |
| Fluoxetine Treatment of Depression in Down Syndrome Fluoxetine - Down Syndrome, Depression | Phase 4 | Completed | Massachusetts General Hospital | 4 | 2022-12-05 | 2025-03-30 |
| Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform Problem Management Plus, Antidepressant Therapy - Depressive Disorder | Phase 4 | Completed | RAND | 487 | 2021-09-01 | 2026-06-09 |
| Fluoxetine to Reduce Intubation and Death After COVID19 Infection Fluoxetine - COVID-19, Cytokine Storm | Phase 4 | Completed | University of Toledo Health Science Campus | 16 | 2020-05-01 | 2024-06-07 |
| Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment Vortioxetine, Sertraline, citalopram - Major Depressive Disorder | Phase 4 | Completed | Azienda Ospedaliera Universitaria Integrata Verona | 362 | 2019-02-01 | 2023-05-19 |
| Identifying and Treating Depression in Hemodialysis Patients Fluoxetine - Depression, Hemodialysis-Induced Symptom | Phase 4 | Completed | MetroHealth Medical Center | 16 | 2018-03-01 | 2024-10-17 |
| Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics Fluoxetine, fluoxetine + cognitive-behavioral treatment(CBT), fluoxetine + Amfebutamone - Depressive Disorder | Phase 4 | Unknown | Shanghai Mental Health Center | 800 | 2017-08-01 | 2017-10-10 |
| Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic Stroke Fluoxetine, Placebo, fMRI - Stroke | Phase 4 | Completed | University Hospital, Toulouse | 25 | 2017-02-27 | 2023-08-28 |
| Bupropion for Depression in ESRD Patients on Hemodialysis Fluoxetine, Bupropion - Major Depression, End Stage Renal Disease | Phase 4 | Terminated | University of Arkansas | 1 | 2016-03-31 | 2018-07-17 |
| Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF. Antidepressants, Positron Emission Tomography (PET) - Bulimia Nervosa | Phase 4 | Completed | Centre Hospitalier Universitaire de Saint Etienne | 51 | 2015-11-09 | 2022-11-30 |
| 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression Lamotrigine, Fluoxetine - Bipolar Disorder | Phase 4 | Terminated | Mayo Clinic | 2 | 2015-03-01 | 2019-06-19 |
| Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging Fluoxetine, Citalopram - Bipolar Disorder | Phase 4 | Completed | New York State Psychiatric Institute | 40 | 2015-01-01 | 2024-12-31 |
| Fluoxetine vs Aripiprazole Comparative Trial (FACT) Aripiprazole, Fluoxetine - Attenuated Psychosis Syndrome | Phase 4 | Terminated | Northwell Health | 9 | 2014-07-01 | 2023-11-15 |
| Measurement-based Care for Depression in Resource-Poor Settings Fluoxetine, Enhanced Usual Care - Major Depression | Phase 4 | Completed | Florida International University | 140 | 2014-02-01 | 2016-12-01 |
| Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients Fluoxetine, Sertraline, Paroxetine - Obsessive-Compulsive Disorder, Anxiety Disorders | Phase 4 | Completed | Shanghai Mental Health Center | 78 | 2014-01-01 | 2022-09-09 |
| Effects of Treatment on Decision-making in Major Depression Any FDA Approved Antidepressant - Major Depressive Disorder, Healthy Controls | Phase 4 | Completed | Emory University | 53 | 2013-08-01 | 2017-11-21 |
Showing 20 of 60. Sign in to see all of them.
Depression (20) · Depressive Disorder, Major (16) · Bipolar Disorder (8) · Obsessive-Compulsive Disorder (5) · Depressive Disorder (4) · Suicide (4) · Alcoholism (3) · Anxiety Disorders (2) · Borderline Personality Disorder (2) · Kidney Failure, Chronic (2) · Self-Injurious Behavior (2) · Alcohol-Related Disorders (1) · Anorexia Nervosa (1) · Body Dysmorphic Disorders (1) · Breast Feeding (1)
New York State Psychiatric Institute (7) · Eli Lilly and Company (3) · Massachusetts General Hospital (3) · Shanghai Mental Health Center (3) · University of Pennsylvania (3) · National Cheng-Kung University Hospital (2) · University of California, Los Angeles (2) · University of Florida (2) · University of Sao Paulo (2) · Wake Forest University Health Sciences (2) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Capital Medical University (1) · Centre Hospitalier Universitaire Vaudois (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Creighton University (1)
United States (33) · China (5) · France (3) · Taiwan (3) · Brazil (2) · Israel (2) · Germany (1) · Ghana (1) · Haiti (1) · Italy (1) · Malawi (1) · Nigeria (1) · Poland (1) · Puerto Rico (1) · Spain (1)
Alan Apter, MD (1) · Allan Kaplan, MD (1) · Andrew F Leuchter (1) · Angela L Ofori-Atta, PhD (1) · Ash Seghal, MD (1) · B. Timothy Walsh, MD (1) · Barbara H. Stanley, PhD (1) · Barbara Stanley, PhD (1) · Boadie W Dunlop, MD (1) · Chantal Csajka, Prof PhD (1) · Ching-Hua Lin, M.D. (1) · Christoph Correll, MD (1)
PMID 19578654, PMID 33884617, PMID 11806859, PMID 12874492, PMID 1438661, PMID 14627997, PMID 14639062, PMID 15729083, PMID 15910213, PMID 16086624, PMID 16772623, PMID 16946178, PMID 17014022, PMID 19574030, PMID 19593175, PMID 20187924, PMID 20360317, PMID 20478741, PMID 20579510, PMID 20726279, PMID 21095016, PMID 21447050, PMID 21601519, PMID 21672502, PMID 21907540, PMID 22020357, PMID 22027844, PMID 22116638, PMID 22273276, PMID 22334811, PMID 22841131, PMID 23099447, PMID 23132334, PMID 23948637, PMID 24552630, PMID 24995027, PMID 25080392, PMID 27984559, PMID 28577548, PMID 28841824, PMID 28900756, PMID 28915895, PMID 29355886, PMID 29433613, PMID 30561642, PMID 32162723, PMID 32368793, PMID 32746941, PMID 33116533, PMID 34011310
R01MH061017 (2), 2005 (1), 2015 (1), 2016 (1), 2018 (1), K43TW011995 (1), P20AA015630 (1), R01AR045416 (1), R01MH045802 (1), R01MH060271 (1), R01MH060336 (1), R01MH060353 (1), R01MH080097 (1), R01MH080098 (1), R01MH080270 (1)